Life Sciences
Top stories summarized by our editors
7/18/2018

Anellotech's thermo catalytic biomass conversion technology is being used to produce biobased plastic bottles derived from biomass feedstock materials, such as sugar cane bagasse, wood and sawdust, through a partnership with Suntory, and the project has achieved milestones. "Having collaborated with Suntory since 2012 to advance development of cost-competitive bioaromatics, we hope biobased plastics made from our Bio-TCat process and a 100% biobased bottle soon become a reality," says Anellotech President and CEO David Sudolsky.

Full Story:
Bio-Based World News
More Summaries:
Suntory, Anellotech
7/18/2018

Johnson & Johnson expects to continue implementing innovation-driven strategies in its medical device group, focusing on product launches, acquisitions and research and development spending. The company also has sold its Calibra wearable insulin pump, branded OneTouch Via, to CeQur for undisclosed terms.

More Summaries:
Johnson & Johnson, CeQur
7/18/2018

A round of funding has brought in $25 million for Switzerland-based preclinical medtech group Polares Medical. The proceeds will be used to support clinical evaluation of the company's mitral valve repair technology.

Full Story:
MassDevice (Boston)
7/18/2018

Irvine, Calif.-based LensGen has raised $11 million in clinical performance milestone-based funding, plus an additional $4.4 million from lead investor Hoya, in a round of Series A financing. The company, developer of the Juvene intraocular lens for vision restoration in patients with presbyopia and cataracts, is also adding lab and office space to support workforce growth, manufacturing and research and development.

Full Story:
MassDevice (Boston)
More Summaries:
LensGen, Cataracts, HOYA
7/18/2018

Medtronic, GE Healthcare and Change Healthcare will be awarded grants worth $5.5 million to $14 million to help them expand their research and development centers in Israel under a six-year program.

Full Story:
CTech (Israel)
More Summaries:
Medtronic, Change Healthcare
7/18/2018

A partnership has been reached by Reva Medical with Bio Vascular Group, allowing the latter to handle Italian distribution of Reva's Fantom bioresorbable scaffold. Reva also has completed the first implantation of the Fantom device in the country.

More Summaries:
Reva Medical, Reva
7/18/2018

Children with aural atresia had their mean Hearing in Noise Test scores increase from 75.3% to 93.6% after receiving transcutaneous osseointegrated implantation, researchers reported in JAMA Otolaryngology -- Head & Neck Surgery. The implants were also well-tolerated, significantly reduced complications and yielded high patient and parent satisfaction, but other hearing rehabilitation options, such as osseointegrated hearing aids and canalplasty are also options, according to an accompanying editorial.

More Summaries:
Neck Surgery
7/18/2018

An initial order has been placed by Nemaura Medical with its UK-based contract manufacturer for 12,500 rechargeable transmitters as it gears up for the European launch of its sugarBeat glucose monitoring system. The company is awaiting CE mark approval for the system, which comes with a disposable, adhesive patch that enables glucose data transmission to a mobile app every five minutes.

More Summaries:
Nemaura Medical, EU, EU
7/18/2018

The FDA has given K2M 510(k) clearance for its Cayman United Plate System. The system, which is intended to provide rigid fixation to the company's Cascadia Lateral 3D Interbody System, has also been granted CE mark approval by European regulators.

Full Story:
Becker's Spine Review
More Summaries:
FDA
7/18/2018

A new drug to treat Alzheimer's disease improved cognition in patients taking part in a trial. Researchers from Ocean University of China, Shanghai Institute of Materia Medica under the Chinese Academy of Sciences and Green Valley Pharmaceutical have been studying the drug, GV-971, for 21 years.